Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment.

MLA

Foggetti, Giorgia, et al. “Tumor Suppressor Pathways Shape EGFR-Driven Lung Tumor Progression and Response to Treatment.” Molecular & Cellular Oncology, vol. 9, no. 1, Jan. 2022, p. 1994328. EBSCOhost, https://doi.org/10.1080/23723556.2021.1994328.

APA

Foggetti, G., Li, C., Cai, H., Petrov, D. A., Winslow, M. M., & Politi, K. (2022). Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment. Molecular & Cellular Oncology, 9(1), 1994328. https://doi.org/10.1080/23723556.2021.1994328

Chicago

Foggetti, Giorgia, Chuan Li, Hongchen Cai, Dmitri A Petrov, Monte M Winslow, and Katerina Politi. 2022. “Tumor Suppressor Pathways Shape EGFR-Driven Lung Tumor Progression and Response to Treatment.” Molecular & Cellular Oncology 9 (1): 1994328. doi:10.1080/23723556.2021.1994328.